4JAMES C V,DAVID A G,EMMANUEL L B’et al.Successful outcomes in pheochromocytoma in the modemera[j]. J Urol,2004,166(26):765 - 766.
5HIRCHE T 0,IGNEE A,HIRCHE H,et al. Evaluation ofhep-atic steatosis by ultrasound in patients with chronichepatitis cvirus infection [J]. Liver Int,2007,27 (6):748 - 757.
6American Thyroid Association Guidelines Task Force. Medullary thyroid cancer:management guidelines of the American Thyroid Association[J].Thyroid:Official Journal of the American Thyroid Association,2009,(16):565-612.
7Qi XP,Ma JM,Du ZF. RET germline mutations identified by exome sequencing in a Chinese multiple mndocrine neoplasia type 2A/familial medullary thyroid carcinoma family[J].PLoS One,2011,(05):e20353(1-e20353(9.
8Qi XP,Ying RB,Ma JM. Case report:a p.C618S RET protooncogene germline mutation in a large Chinese pedigree with familial medullary thyroid carcinoma[J].Familial Cancer,2012,(01):131-136.
9Qi XP,Chen XL,Ma JM. RET proto-oncogene genetic screening of families with multiple endocrine neoplasia type 2 optimizes diagnostic and clinical management in China[J].Thyroid:Official Journal of the American Thyroid Association,2012,(12):1257-1265.
10Brauckhoff M,Stock K,Stock S. Limitations of intraoperative adrenal remnant volume measurement in patients undergoing subtotal adrenalectomy[J].World Journal of Surgery,2008,(05):863-872.
